|
 |
| |
Staff Bio
Samuel R. Friedman, Ph.D.
Position Title - Core Director, Theoretical Synthesis Core, CDUHR
- Principal Investigator
- Senior Research Fellow, NDRI
Affiliation National Development and Research Institutes
Education Ph.D., Sociology, University of Michigan
Research Interests - Macrosocial change (wars, transitions, economic crises, etc) and the international epidemiology of HIV, STIs, other blood-borne viruses, drug use, and disease prevention
- Social structures of inequality and subordination (racism, gender, heterosexism) and the epidemiology of HIV, STIs, other blood-borne viruses, and drug use
- Community characteristics and their effects on HIV transmission, IDUs per capita, and prevention policies and programs
- Injection networks, sexual networks, and social networks
- Social aspects of vaccine implementation
- Social and structural interventions
- Prevention approaches
- Drug users’ collective organizations and activities
Current Projects - Principal Investigator, Community Vulnerability and Responses to Drug-User-Related HIV/AIDS (CVAR)
- Principal Investigator, Staying Safe: Long-Term IDUs Who Avoided HIV & HCV
- Co-Investigator, Risk Factors for HIV/AIDS in Drug Users
Awards and Memberships - Scientific Advisory Board, Canadian Network for Vaccines and Immunotherapeutics of Cancer and Chronic Viral Diseases (CANVAC), 2000 -
- Scientific Advisory Board, University of Miami Drug Abuse and AIDS Research Center (DAARC), 2002 -
- Scientific Committee for Track E (Social Science), XIV International Conference on AIDS, Barcelona, 2002
- Committee on Lesbian Health Research Priorities, National Academy of Sciences/Institute of Medicine, 1997
- Natural History, Epidemiology, and Prevention Research Area Review Panel of the NIH AIDS Research Program Evaluation Working Group, 1995-1996. (Also, Chair of its sub-panel on drug-related transmission.)
- Steering Committee for the Workshop on the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention, National Academy of Sciences/Institute of Medicine, 1995-1996
- Educational Policy Advisory Committee, American Foundation for AIDS Research, 1991-1993
- Committee on Lesbian Health Research Priorities, National Academy of Sciences/Institute of Medicine, 1997
- Editorial Board Member, Journal of Acquired Immune Deficiency Syndromes
- Associate Editor (Social Science), The International Journal on Drug Policy
- Advisory Editor, AIDS Education and Prevention: An Interdisciplinary Journal
- International Editorial Board Member, The Drug and Alcohol Professional
- Career Award, Sociologists AIDS Network, Americanl Sociological Association, 2007
Academic Appointments - Senior Associate, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University
|
|
Des Jarlais, D. C., Arasteh, K., McKnight, C., Ringer, M., & Friedman, S. R. (2010). Syringe exchange, injecting and intranasal drug use. Addiction, 105 (1), 155-158.
|
|
Booth, R. E., Des Jarlais, D. C., & Friedman, S. R. (2009). Reflections on 25 years of HIV and AIDS research among drug abusers. Journal of Drug Issues, 39 (1), 209-222.
|
|
Cooper, H. L., Bossak, B. H., Tempalski, B., Friedman, S. R., & Des Jarlais, D. C. (2009). Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: Relationship to local racial/ethnic composition and need. Journal of Urban Health, 86 (6), 929-945.
|
|
Cooper, H. L., Bossak, B., Tempalski, B., Des Jarlais, D. C., & Friedman, S. R. (2009). Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy, 20 (3), 217-226.
|
|
Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D. C., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99 (Suppl 2), S445-S451.
|
|
Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Friedman, S. R. (2009). Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence, 101 (1-2), 88-91.
|
|
Friedman, C. R., & Friedman, S. R. (2009). Incentives increase enrolment in substance abuse treatment at community needle exchange site. Evidence-Based Mental Health, 12 (4), 121.
|
|
Friedman, S. R., Cooper, H. L., & Osborne, A. H. (2009). Structural and social contexts of HIV risk among African Americans. American Journal of Public Health, 99 (6), 1002-1008.
|
|
Friedman, S. R., Mateu-Gelabert, P., & Sandoval, M. (2009). A dialogue on the incapability/capability of injection drug users. Substance Use and Misuse, 44 (13), 1971-1978.
|
|
Friedman, S. R., Rossi, D., & Braine, N. (2009). Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. International Journal of Drug Policy, 20 (3), 283-291.
|
|
Friedman, S. R., Rossi, D., & Phaswana-Mafuya, N. (2009). Globalization and interacting large-scale processes and how they may affect the HIV/AIDS epidemic. In C. Pope, R. T. White, & R. Malow (Eds.), HIV/AIDS: Global frontiers in prevention/intervention (491-499). New York: Routledge.
|
|
Hacker, M. A., Leite, I., Friedman, S. R., Carrijo, R. G., & Bastos, F. I. (2009). Poverty, bridging between injecting drug users and the general population, and "interiorization" may explain the spread of HIV in southern Brazil. Health and Place, 15 (2), 514-519.
|
|
Khan, M. R., Bolyard, M., Sandoval, M., Mateu-Gelabert, P., Krauss, B., Aral, S. O., & Friedman, S. R. (2009). Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York. Journal of Acquired Immune Deficiency Syndromes, 51 (1), 470-485.
|
|
Tempalski, B., Lieb, S., Cleland, C. M., Cooper, H., Brady, J. E., & Friedman, S. R. (2009). HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. Journal of Urban Health, 86 (1), 132-154.
|
|
Brady, J. E., Friedman, S. R., Cooper, H. L., Flom, P. L., Tempalski, B., & Gostnell, K. (2008). Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of Urban Health, 85 (3), 323-351.
|
|
Braine, N., Acker, C., Goldblatt, C., Yi, H., Friedman, S., & Des Jarlais, D. C. (2008). Neighborhood history as a factor shaping syringe distribution networks among drug users at a U.S. syringe exchange. Social Networks, 30 (3), 235-246.
|
|
Cooper, H. L. F., Friedman, S. R., Tempalski, B., & Friedman, R. (2008). Residential segregation and the prevalence of injection drug use among Black adult residents of US metropolitan areas. In Y. F. Thomas, D. Richardson, & I. Cheung (Eds.), Geography and drug addiction (145-157). New York: Springer.
|
|
Cooper, H. L., Brady, J. E., Ciccarone, D., Tempalski, B., Gostnell, K., & Friedman, S. R. (2008). Reply to Chai et al.. Clinical Infectious Diseases, 46 (6), 955-956.
|
|
Cooper, H. L., Brady, J. E., Friedman, S. R., Tempalski, B., Gostnell, K., & Flom, P. L. (2008). Estimating the prevalence of injection drug use among Black and White adults in large U.S. metropolitan areas over time (1992-2002): Estimation methods and prevalence trends. Journal of Urban Health, 85 (6), 826-857.
|
|
Friedman, S. R., Bolyard, M., Khan, M., Maslow, C., Sandoval, M., Mateu-Gelabert, P., Krauss, B., & Aral, S. O. (2008). Group sex events and HIV/STI risk in an urban network. Journal of Acquired Immune Deficiency Syndromes, 49 (4), 440-446.
|
|
Friedman, S. R., Bolyard, M., Sandoval, M., Mateu-Gelabert, P., Maslow, C., & Zenilman, J. (2008). Relative prevalence of different sexually transmitted infections in HIV-discordant sexual partnerships: Data from a risk network study in a high-risk New York neighbourhood. Sexually Transmitted Infections, 84 (1), 17-18.
|
|
Friedman, S. R., Mateu-Gelabert, P., Sandoval, M., Hagan, H., & Des Jarlais, D. C. (2008). Positive deviance control-case life history: A method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health, 8 (1), 94.
|
|
Friedman, S. R., Tempalski, B., Cooper, H., Lieb, S., Brady, J., Flom, P. L., Friedman, R., Gostnell, K., & Des Jarlais, D. C. (2008). Metropolitan area characteristics, injection drug use and HIV among injectors. In Y. F. Thomas, D. Richardson, & I. Cheung (Eds.), Geography and drug addiction (255-265). New York: Springer.
|
|
Mateu-Gelabert, P., Bolyard, M., Maslow, C., Sandoval, M., Flom, P. L., & Friedman, S. R. (2008). For the common good: Measuring residents' efforts to protect their community from drug- and sex-related harm. Journal of Social Aspects of HIV/AIDS (SAHARA J), 5 (3), 144-157.
|
|
Neaigus, A., Zhao, M., Gyarmathy, V. A., Cisek, L., Friedman, S. R., & Baxter, R. C. (2008). Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. Journal of Urban Health, 85 (3), 309-322.
|
|
Page(s)
|
| 1 2 3 4 5 6 7 8 9 10 ... |
|
| |
|
|
|
 |